These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29478888)

  • 1. Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Jun DW; Lee S
    Clin Nutr; 2018 Jun; 37(3):1090. PubMed ID: 29478888
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Lee SM; Jun DW
    Clin Nutr; 2018 Apr; 37(2):759. PubMed ID: 29366517
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Khosravi Shadmani F; Khazaei S; Mansouri Hanis S; Mansori K
    Clin Nutr; 2018 Apr; 37(2):758. PubMed ID: 29373149
    [No Abstract]   [Full Text] [Related]  

  • 4. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to the Letter to the Editor on "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children".
    Zhang J
    Horm Metab Res; 2024 Jun; 56(6):472. PubMed ID: 38698580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey - author's reply.
    Wong RJ
    Aliment Pharmacol Ther; 2018 Sep; 48(5):585-586. PubMed ID: 30156318
    [No Abstract]   [Full Text] [Related]  

  • 8. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
    Al-Dayyat HM; Rayyan YM; Tayyem RF
    Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases".
    Turan Y
    Angiology; 2020 Jan; 71(1):88. PubMed ID: 31597437
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.
    Kim M; Jun DW
    Clin Nutr; 2020 Jan; 39(1):306. PubMed ID: 31812470
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".
    Kutlu O; Altun Ö; Dikker O; Aktaş Ş; Özsoy N; Arman Y; Özgün Çil E; Özcan M; Aydın Yoldemir Ş; Akarsu M; Toprak İD; Kırna K; Kutlu Y; Toprak Z; Eruzun H; Tükek T
    Med Princ Pract; 2020; 29(1):98. PubMed ID: 31505512
    [No Abstract]   [Full Text] [Related]  

  • 13. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study.
    Chan DF; Nelson EA; Li AM; Woo J; Sea MM; Chan RS; Chu WC; Chan M; So HK
    Hong Kong Med J; 2018 Aug; 24 Suppl 4(4):12-15. PubMed ID: 30135268
    [No Abstract]   [Full Text] [Related]  

  • 15. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.
    Wang Q; Zheng D; Liu J; Fang L; Li Q
    Lipids Health Dis; 2018 Dec; 17(1):284. PubMed ID: 30545385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?".
    Turan Y; Demir V; Turan E; Hidayet Ş
    Angiology; 2020 Jan; 71(1):85-86. PubMed ID: 31450946
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
    Wei JL; Leung JC; Loong TC; Wong GL; Yeung DK; Chan RS; Chan HL; Chim AM; Woo J; Chu WC; Wong VW
    Am J Gastroenterol; 2015 Sep; 110(9):1306-14; quiz 1315. PubMed ID: 26215532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
    Reinehr T; Woelfle J; Wunsch R; Roth CL
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease.
    Katsagoni CN; Papatheodoridis GV; Papageorgiou MV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Fragopoulou E; Kontogianni MD
    Appl Physiol Nutr Metab; 2017 Mar; 42(3):250-256. PubMed ID: 28133993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.